Evidence map›Paper›PMID 39558421›Full record

ReviewCancer imaging : the official publication of the International Cancer Imaging Society2024

Nuclear medicine imaging in non-seminomatous germ cell tumors: lessons learned from the past failures.

Narjess Ayati, Emran Askari, Maryam Fotouhi, Masume Soltanabadi, Atena Aghaee, Hesamoddin Roustaei, Andrew M Scott

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer imaging : the official publication of the International Cancer Imaging Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [EJNMMI research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Narjess Ayati *Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia.
Emran Askari *Nuclear Medicine Research Center, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran.
Maryam FotouhiAdvanced Diagnostic and Interventional Radiology Research Center (ADIR), Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Masume SoltanabadiRajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Atena AghaeeNuclear Medicine Research Center, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran.
Hesamoddin RoustaeiDepartment of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
Andrew M ScottTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia. andrew.scott@austin.org.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an unmet need for a more accurate molecular imaging radiotracer in the field of non-seminomatous germ cell tumors (NSGCT). The clinical problem is that no single imaging modality is able to differentiate teratoma from necrotic tissue in NSGCTs, which the nuclear medicine techniques are no exception. The exponential growth in the list of potentially promising radiotracers may hold promise in the future for imaging of NSGCTs. Here, we have reviewed the past efforts and potential future advances in this field.

Indexed as

Neoplasms, Germ Cell and EmbryonalTesticular NeoplasmsHumansMaleNuclear MedicineRadiopharmaceuticalsTeratomaRadiopharmaceuticalsImagingNon-seminomatous germ cell tumorRadiotracerRetroperitoneal residual massTeratoma

Identifiers

PMID39558421
PMCPMC11571929

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.